In­ter­cept shake­up con­tin­ues as CMO, for­mer NASH chief re­signs. Is the NASH biotech aban­don­ing its flag­ship dis­ease?

First, they said good­bye to their found­ing CEO af­ter 18 years. Now, In­ter­cept is los­ing its CMO too, an ex­ec­u­tive who led the com­pa­ny’s flag­ship NASH pro­gram for much of its clin­i­cal de­vel­op­ment.

In­ter­cept re­vealed in an SEC fil­ing Mon­day that Ja­son Cam­pagna ten­dered his res­ig­na­tion and will leave the com­pa­ny on March 5. His de­par­ture comes three months af­ter the com­pa­ny abrupt­ly an­nounced they were re­plac­ing long­time CEO Mark Pruzan­s­ki with COO and for­mer Sanofi com­mer­cial chief Jer­ry Dur­so.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER